Basel Medical Group Ltd Ordinary Shares (BMGL) — Strategic Asset Allocation Index
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Strategic Asset Allocation Index of 0.0% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $49.00) total $49.00, measured against net assets of $4.86 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Basel Medical Group Ltd Ordinary Shares Strategic Asset Allocation Index (2024–2025)
This chart shows how Basel Medical Group Ltd Ordinary Shares's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of June 2025, the index stands at 0.0%, representing strategic assets of $49.00 against net assets of $4.86 Million USD. Explore BMGL cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Basel Medical Group Ltd Ordinary Shares (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Basel Medical Group Ltd Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Basel Medical Group Ltd Ordinary Shares stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $49.00 | $- | $49.00 | $4.86 Million | ▲ +0.0 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $7.56 Million | — |